Prevalence of enteric parasitic infections among people living with HIV in Abeokuta, Nigeria

Prevalence of enteric parasitic infections among people living with HIV in Abeokuta, Nigeria

John Kehinde Amoo¹, Akeem Abiodun Akindele², Abimbola Oladipupo Joseph Amoo¹, Akinwale Michael Efunshile^1,3, Taiwo Adetola Ojurongbe⁴, Samuel Adetona Fayemiwo⁵, Bolaji Nun Thomas⁶, Olusola Ojurongbe^2,&

 

¹Department of Medical Microbiology & Parasitology, Olabisi Onabanjo University, Ago-Iwoye, Nigeria, ²Department of Medical Microbiology & Parasitology, Ladoke Akintola University of Technology, Osogbo, Nigeria, ³Department of Medical Microbiology, Ebonyi State University, Abakaliki, Nigeria, ⁴Department of Mathematical and Physical Sciences, Osun State University, Osogbo, Nigeria, ⁵Department of Medical Microbiology, College of Medicine, University of Ibadan, Ibadan, Nigeria, ⁶Department of Biomedical Sciences, College of Health Sciences and Technology, Rochester Institute of Technology, Rochester NY, USA

 

 

^&Corresponding author
Olusola Ojurongbe, Department of Medical Microbiology & Parasitology, Ladoke Akintola University of Technology, PMB 4400, Osogbo, Osun State, Nigeria

 

 

 

 

Enteric parasitic infections are important and common features of Human Immunodeficiency Virus infection (HIV), causing significant morbidity and responsible for about 80% of Acquired Immune Deficiency Syndrome (AIDS)-related deaths [1,2]. Co-infections of HIV and opportunistic parasites, including intestinal protozoa and helminths, are of concern in resource-poor settings where the health status of the population is generally poor and these opportunistic parasites very common [3]. The resultant effect of such parasitic infections include chronic diarrhea, weight loss, and malnutrition, which has been associated with death among AIDS patients [4]. HIV has the capacity to circumvent and weaken human immune system providing the impetus for increased infection with parasites such as Cryptosporidium spp., Microsporidium spp, Giardia intestinalis, and Strongyloides (S) stercoralis [4].

 

Cryptosporidium spp, Microsporidia and other coccidian parasites have emerged as significant causes of persistent diarrhea in People living with HIV/AIDS (PLWHA) [5]. These pathogens have been recognized as worldwide causes of diarrhea in all age groups, yet their most significant impact have been felt among individuals with weakened immune systems, especially PLWHA and organ transplant recipients [6]. In immunocompromised individuals, diarrheal infections go beyond the inconvenience of frequent watery stool but may result in severe and potentially life-threatening dehydration, electrolyte loss and malnutrition, and eventually death [7]. Transmission of Cryptosporidium is mainly through the fecal-oral route in contaminated water and food, as well as through person-to-person spread and contact with infected animals [8]. Microsporidiosis, caused by Microsporidia, another important opportunistic pathogen causing significant morbidity in PLWHA [9], is also associated with life-threatening chronic diarrhea and systemic disease [10] and are caused by members of Enterocytozoon and Encephalitozoon genera [11]. The route of transmission is usually by ingestion of the spores, including evidence of spore inhalation or rectal transmission [12].

 

Nigeria has the highest number of PLWHA (3.2 million) after South Africa (6.8 million) [13]. HIV causes progressive depletion of the CD4+ T cells, leading to life-threatening opportunistic infections during the natural course of the disease [14]. In immunocompromised patients, the intestinal parasites play a major role in causing chronic diarrhea accompanied by weight loss [15], with diarrhea reported in up to 50% of PLWHA in developed countries prior to the use of antiretroviral therapy (ART), and in up to 80% of those in resource-limited countries [14,16]. Antiretroviral therapy increases the length and quality of life and productivity of patients by improving survival and decreasing the incidence of opportunistic infections in PLWHA through the reduction of circulating viremia and increasing the level of CD4+ cells [16]. Previous studies in Nigeria have investigated intestinal parasitic infections in relation to ART and CD4+ count [17,18]. There is therefore the need for continuous surveillance of the prevalence and impact of these intestinal parasites among PLWHA, so as to provide guidance on prevention and control of co-infections, as well as reducing associated morbidity and mortality.

 

 

Study area: this cross-sectional study was conducted at the HIV clinic of Federal Medical Centre, Abeokuta, Nigeria. This is one of the main treatment facilities for PLWHA in Abeokuta, Southern Nigeria.

 

Ethics statement: this study was approved by the Institutional Review Board of the Federal Medical Centre, Abeokuta, Nigeria. All participants gave informed consent before samples were collected and processed. General information regarding the nature of the study and its objectives was explained to participants, who were also informed of the right of refusal to participate in the study or to withdraw at any time, without jeopardizing their right of access to other health services. Identification numbers were used instead of names and information collected was kept confidential.

 

Study population: PLWHA positively confirmed patients, attending the HIV outpatient clinic of Federal Medical Centre, Abeokuta, Nigeria, who willingly gave informed consent and volunteered to have their stool samples examined were recruited into the study. Patients were attending clinic for routine check-up, collection of medications or other medical complaints. HIV status was confirmed using Determine HIV1/2 kit (Abbott Diagnostic Division, Hoofddorp, The Netherlands), followed by Unigold or Stat-Pak assay concurrently according to serial algorithm of the Federal Government of Nigeria. Socio-demographic data of the patients were collected.

 

Sample collection and staining methods: fresh stool samples were collected in clean universal bottles labeled with each patient's details. Thin smears were made from all fecal samples and stained with Webe's Cromothrope stain and Kinyoun stain to detect the presence of microsporidia and Cryptosporidium spp respectively [19,20]. Blood samples were analyzed for CD4+ T cell estimates by flow cytometry. Patients with loose/ watery stool who also confirmed the passage of such stool for 2 to 3 times within the last 24 hours were considered to be having diarrhea.

 

Data analysis: data were analyzed using SPSS version 16.0 (SPSS Inc. Chicago, IL, USA). Prevalence of enteric parasites among PLWHA was compared to CD4+ T cell count, presence or absence of diarrhea and the use of ART using Pearson's chi-square (χ²) test or Fisher's exact test, where appropriate. Statistical significance for all analyses was determined at 5% level of significance.

 

 

A total of 231 PLWHA were enrolled into the study. Their mean age was 31.81±11.40 years (range: 16-59 years; 135 [58.4%] females, 96 [41.6%] males). Majority (95.2%) had CD4+ cell count ≤200 cells/mm³. Eighty four (36.4%) harbored at least one of the following parasites; Cryptosporidium spp. (22.5%), Microsporidium spp (3.0%), Ascaris (A) lumbricoides (20.8%), hookworms (6.5%), S. stercoralis (4.3%), T. trichiura (5.6%) and Taenia spp. (5.6%). Table 1 shows the general characteristics of our study group and the distribution of intestinal parasites detected in stool samples. The distribution of opportunistic intestinal parasites with respect to CD4+ cell count is presented in Table 2. All the intestinal parasites seen in the study were more prevalent in PLWHA with CD4+ cell count ≤ 200 cells/mm³. Cryptosporidium spp. (80.8%), Microsporidium spp. (71.4%) and S. stercoralis (70.2%) were significantly higher in PLWHA with CD4+ count ≤ 200 cells/mm³ compared those with CD4+ count ≤ 200 cells/mm³. Table 3 shows the relationship between intestinal parasites and diarrhea in the study population. One hundred and twenty four (53.7%) of the PLWHA presented with diarrhea-related diseases like extremely watery faeces and cramping abdominal pains. Cryptosporidium spp oocyst was seen in 84.6% of PLWHA with diarrhea, which was statistically significant (p=0.006) when compared with those without diarrhea (15.4%). Table 4 shows the distribution of intestinal parasite species among PLWHA that are anti-retroviral therapy (ART)-naïve and those on ART. The naïve ART PLWHA were generally more infected with the intestinal parasites in comparison to those PLWHA already on ART. A strongly statistical significant difference was observed for Cryptosporidium spp (ART 26.9% vs Naïve ART 73.1%; p = 0.000) and A. lumbricoides (ART 16.7% vs Naïve ART 83.3%; p=0.001).

 

 

Parasitic infections are major public health concern among PLWHA in developing countries, particularly in sub-Saharan Africa, with its high burden of HIV infections [21]. Down-regulation of the immune system, a hallmark of HIV infection, renders an individual extremely susceptible to numerous opportunistic parasitic infections [22]. Among such infections, gastrointestinal parasites are some of the leading causes of morbidity and mortality in, and are a universally recognized problem in PLWHA [21-23]. In this study, the overall prevalence of intestinal parasitic infection among PLWHA was found to be 36.4%. The result is almost similar to the findings from Ethiopia [8], Cameroon [23], and Saudi Arabia [24], but lower than those previously reported in Nigeria [18], India [25], Cameroon [26] and Lao PDR [27]. Such differing prevalence rates might be due to differences in geographical location, sensitivity of diagnostic techniques, immune status of study participants, environmental hygiene and possible increased awareness, amongst others. Several species of intestinal opportunistic parasites have been reported among PLWHA [16], with Cryptosporidium spp, Microsporidium spp and S. stercoralis the most commonly encountered in this study. Cryptosporidium spp, which was found to be responsible for diarrhea in 10-20% of PLWHA worldwide [28], has been reported among PLWHA in Nigeria [29], and more importantly in those with CD4+ T-cell counts of less than 200 cells/mm³ [18]. The prevalence of Cryptosporidium spp in this study was 22.5%, and lower than the findings from other studies (range 44-55%) [18,30,31]. The relatively lower prevalence of the parasites in this study might be due to difference in immunity, diarrheic status, environmental and personal hygiene of the study participants. This study further confirms previous reports that increased susceptibility of HIV-seropositive individuals to parasitic infections is associated with CD4+ T-cell counts less than 200 cells/mm3. At higher CD4+ T-cell count, spontaneous clearing of the parasites take place [18,32]. Cryptosporidium spp, Strongyloides stercoralis and Microsporidia spp were observed to be significantly associated with lower CD4+ T cell count. Cellular immunity is the major defense against intestinal parasitic infections. The reduction in CD4+ T cell count by the virus predisposes PLWHA to these opportunistic parasitic infections.

 

Microsporidiosis in PLWHA remain challenging and the prevalence reported in our study (3%) was lower than those reported in previous studies in Nigeria [10,33,34]. Most of the positive samples were identified among PLWHA with CD4+ count less than 200 cells/µl. Similar results were previously reported in other countries [5,35-37]. Additionally, most of the positive samples were identified in diarrheic stools (85.7%) and only 14.3% in formed stools. A possible reason for the low prevalence rates could be lack of molecular or immune-fluorescent techniques, which are more sensitive for diagnosis of Microsporidium spp. and could have benefited our study. Five helminths (A. lumbricoides, hookworm, S. stercoralis, Taenia spp and T. trichiura) were detected in this study. A very high prevalence of A. lumbricoides (20.8%) and hookworm (6.5%) was observed. Surprisingly, the prevalence of S. stercoralis was very low (4.3%) in our study population, which was expected to have the highest prevalence, being commonly implicated in immuno-compromised individuals. From this study, it is clear that there are no specific prevalence patterns of intestinal helminths among PLWHA. Distribution of parasites may depend on ecological variation and behavioral activities.

 

Limited evidence suggests that antiretroviral therapy (ART) reduces prevalence of helminth infections in PLWHA [30,38]. In this study, the prevalence of both helminth and protozoa intestinal infections was higher in ART naïve PLWHA compared to those already on ART. The prevalence of both Cryptosporidium spp and A. lumbricoides was significantly higher in ART naïve PLWHA compared to those on ART and the result is similar to the study conducted in Ethiopia [39]. It is commonly reported that the use of ART among PLWHA considerably reduces parasitic infections, especially protozoal infections such as cryptosporidiosis, although the underlying mechanisms remain unclear. Naturally, improved cellular immunity [16,40,41] and overall drug effect of both ART and cotrimoxazole preventive therapy (CTX-P), are the commonly given reasons for the reduction of parasite burden [41-43]. This study show that the prevalence of cryptosporidiosis was significantly higher in PLWHA that presented with diarrhea confirming this parasite as an important opportunistic protozoan causing diarrhea among these individuals in Nigeria [18,29]. Both Cryptosporidium spp. and Microsporidium spp. are capable of actively proliferating under reduced cellular defenses, leading to voluminous intractable diarrhea, severe loss of body fluid and dehydration [1].

 

 

In conclusion, this study reveals a high prevalence of opportunistic parasitic infections, significantly correlated with diarrhea and low CD4+ T cell count among PLWHA in Nigeria. Additionally, reduced prevalence of these opportunistic infections was observed among PLWHA who are already on ART. In view of the high prevalence of cryptosporidiosis and other intestinal parasites and its significant association with diarrhea, prompt surveillance of intestinal parasitic infections utilizing molecular and immune-fluorescent techniques for stool examination and subsequent treatment is therefore recommended. Further study is recommended to understand the actual impact of ART on intestinal parasitic infections among PLWHA.

 

 

The authors declare no competing interests.

 

 

Specify the contribution to the work and write-up of the manuscript for each person listed as author. JKA, AME, AOJA conceived, designed the experiments and participated in sampling; AAA and JKA wrote the first draft of the manuscript; OO and AME jointly developed the structure and arguments for the paper; TAO carried out the statistical analysis; SAF, OO and BNT made critical revisions on scientific content and final version. All authors reviewed and approved of the final version of the manuscript.

 

 

The authors are grateful to all the patients who participated in the study.

 

 

Table 1: general characteristics and distribution of the intestinal parasitic infections among the HIV/AIDS patients

Table 2: distribution of intestinal parasites with respect to CD4+ count

Table 3: distribution of intestinal parasites with respect to diarrhea in HIV-positive individuals

Table 4: distribution of intestinal parasites with respect to ART status in HIV-positive individuals

 

 

1. Kucerova Z, Sokolova OI, Demyanov AV, Kvac M, Sak B, Kvetonova D et al. Microsporidiosis and Cryptosporidiosis in HIV/AIDS Patients in St Petersburg, Russia: Serological identification of microsporidia and Cryptosporidium parvum in sera samples from HIV/AIDS patients. AIDS Res Hum Retroviruses. 2011; 27(1): 13-15. PubMed | Google Scholar


2. Missaye A, Dagnew M, Alemu A, Alemu A. Prevalence of intestinal parasites and associated risk factors among HIV/AIDS patients with pre-ART and on-ART attending dessie hospital ART clinic, Northeast Ethiopia. AIDS Res Ther. 2013; 10(1): 7. PubMed | Google Scholar


3. Tzipori S, Widmer G. A hundred-year retrospective on cryptosporidiosis. Trends Parasitol. 2008; 24(4): 184-189. PubMed | Google Scholar


4. Tian L-G, Wang T-P, Lv S, Wang F-F, Guo J, Yin X-M et al. HIV and intestinal parasite co-infections among a Chinese population: an immunological profile. Infect Dis Poverty. 2013; 2(1): 18. PubMed | Google Scholar


5. Tumwine JK, Kekitiinwa A, Bakeera-Kitaka S, Ndeezi G, Downing R, Feng X et al. Cryptosporidiosis and microsporidiosis in ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus. Am J Trop Med Hyg. 2005; 73(5): 921-92. PubMed | Google Scholar


6. Hunter PR, Nichols G. Epidemiology and Clinical Features of Cryptosporidium Infection in Immunocompromised Patients. Clin Microbiol Rev. 2002; 15(1): 145-154. PubMed | Google Scholar


7. Jha AK, Uppal B, Chadha S, Aggarwal P, Ghosh R, Dewan R. Enteric pathogens, immune status and therapeutic response in diarrhea in HIV/AIDS adult subjects from north India. Curr HIV Res. 2013; 11(4): 326-332. PubMed | Google Scholar


8. Shimelis T, Tassachew Y, Lambiyo T. Cryptosporidium and other intestinal parasitic infections among HIV patients in southern Ethiopia: significance of improved HIV-related care. Parasit Vectors. 2016; 9: 270. PubMed | Google Scholar


9. Didier ES, Weiss LM. Microsporidiosis: not just in AIDS patients. Curr Opin Infect Dis. 2011; 24(5): 490-495. PubMed | Google Scholar


10. Ojuromi OT, Izquierdo F, Fenoy S, Fagbenro-Beyioku A, Oyibo W, Akanmu A et al. Identification and characterization of microsporidia from fecal samples of HIV-positive patients from Lagos, Nigeria. PloS One. 2012; 7(4): e35239. PubMed | Google Scholar


11. Stentiford GD, Becnel JJ, Weiss LM, Keeling PJ, Didier ES, Williams BAP et al. Microsporidia - Emergent Pathogens in the Global Food Chain. Trends Parasitol. 2016; 32(4): 336-348. PubMed | Google Scholar


12. Logan C, Beadsworth MBJ, Beeching NJ. HIV and diarrhoea: what is new? Curr Opin Infect Dis. 2016; 29(5): 486-494. Google Scholar


13. Awofala AA, Ogundele OE. HIV epidemiology in Nigeria. Saudi J Biol Sci. 2016. doi: 10.1016/j.sjbs.2016.03.006. PubMed | Google Scholar


14. Wanyiri JW, Kanyi H, Maina S, Wang DE, Ngugi P, O'Connor R et al. Infectious diarrhoea in antiretroviral therapy-naive HIV/AIDS patients in Kenya. Trans R Soc Trop Med Hyg. 2013; 107(10): 631-638. PubMed | Google Scholar


15. Kulkarni SV, Kairon R, Sane SS, Padmawar PS, Kale VA, Thakar MR et al. Opportunistic parasitic infections in HIV/AIDS patients presenting with diarrhoea by the level of immunesuppression. Indian J Med Res. 2009 Jul; 130(1): 63-67. PubMed | Google Scholar


16. Teklemariam Z, Abate D, Mitiku H, Dessie Y. Prevalence of Intestinal Parasitic Infection among HIV Positive Persons Who Are Naive and on Antiretroviral Treatment in Hiwot Fana Specialized University Hospital, Eastern Ethiopia. Int Sch Res Not. 2013; 2013: e324329. PubMed | Google Scholar


17. Jegede FE, Oyeyi TI, Abdulrahman SA, Mbah HA, Badru T, Agbakwuru C et al. Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria. PloS One. 2017; 12(3): e0174233. PubMed | Google Scholar


18. Ojurongbe O, Raji OA, Akindele AA, Kareem MI, Adefioye OA, Adeyeba AO. Cryptosporidium and other enteric parasitic infections in HIV-seropositive individuals with and without diarrhoea in Osogbo, Nigeria. Br J Biomed Sci. 2011; 68(2): 75-78. PubMed | Google Scholar


19. Weber R, Bryan RT, Owen RL, Wilcox CM, Gorelkin L, Visvesvara GS. Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates: the enteric opportunistic infections working group. N Engl J Med. 1992; 326(3): 161-166. PubMed | Google Scholar


20. Garcia LS. Diagnostic Medical Parasitology. American Society for Microbiology Press. 2006; 5th ed. PubMed | Google Scholar


21. Assefa S, Erko B, Medhin G, Assefa Z, Shimelis T. Intestinal parasitic infections in relation to HIV/AIDS status, diarrhea and CD4 T-cell count. BMC Infect Dis. 2009; 9: 155. PubMed | Google Scholar


22. Paiardini M, Müller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev. 2013; 254(1): 78-101. PubMed | Google Scholar


23. Sarfati C, Bourgeois A, Menotti J, Liegeois F, Moyou-Somo R, Delaporte E et al. Prevalence of intestinal parasites including microsporidia in human immunodeficiency virus-infected adults in Cameroon: a cross-sectional study. Am J Trop Med Hyg. 2006; 74(1): 162-164. PubMed | Google Scholar


24. Al-Megrin WAI. Intestinal parasites infection among immunocompromised patients in Riyadh, Saudi Arabia. Pak J Biol Sci PJBS. 2010; 13(8): 390-394. PubMed | Google Scholar


25. Mathur MK, Verma AK, Makwana GE, Sinha M. Study of Opportunistic Intestinal Parasitic Infections in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients. J Glob Infect Dis. 2013; 5(4): 164-167. PubMed | Google Scholar


26. Nkenfou CN, Nana CT, Payne VK. Intestinal Parasitic Infections in HIV infected and non-infected patients in a low HIV Prevalence Region, West-Cameroon. PLoS ONE. 2013; 8(2). PubMed | Google Scholar


27. Paboriboune P, Phoumindr N, Borel E, Sourinphoumy K, Phaxayaseng S, Luangkhot E et al. Intestinal Parasitic Infections in HIV-Infected Patients, Lao People?s Democratic Republic. PLoS ONE. 2014; 9(3). PubMed | Google Scholar


28. Chacin-Bonilla L, Guanipa N, Cano G, Raleigh X, Quijada L. Cryptosporidiosis among patients with acquired immunodeficiency syndrome in Zulia State, Venezuela. Am J Trop Med Hyg. 1992; 47(5): 582-586. PubMed | Google Scholar


29. Adesiji YO, Lawal RO, Taiwo SS, Fayemiwo SA, Adeyeba OA. Cryptosporidiosis in HIV infected patients with Diarrhoea in Osun State Southwestern Nigeria. Eur J Gen Med. 2007; 4(3): 119-122. PubMed | Google Scholar


30. Nsagha DS, Njunda AL, Assob NJC, Ayima CW, Tanue EA, kibu OD et al. Intestinal parasitic infections in relation to CD4+ T cell counts and diarrhea in HIV/AIDS patients with or without antiretroviral therapy in Cameroon. BMC Infect Dis. 2016; 16. PubMed | Google Scholar


31. Obateru OA, Bojuwoye BJ, Olokoba AB, Fadeyi A, Fowotade A, Olokoba LB. Prevalence of intestinal parasites in newly diagnosed HIV/AIDS patients in Ilorin, Nigeria. Alex J Med. 2016. PubMed | Google Scholar


32. Khalil S, Mirdha BR, Sinha S, Panda A, Singh Y, Joseph A et al. Intestinal Parasitosis in relation to Anti-Retroviral Therapy, CD4(+) T-cell Count and Diarrhea in HIV Patients. Korean J Parasitol. 2015; 53(6): 705-712. PubMed | Google Scholar


33. Akinbo FO, Okaka CE, Omoregie R, Dearen T, Leon ET, Xiao L. Molecular characterization of Cryptosporidium spp, in HIV-infected Persons in Benin City, Edo State, Nigeria. Fooyin J Health Sci. 2010; 2(3): 85-89. PubMed | Google Scholar


34. Ayinmode AB, Ojuromi OT, Xiao L. Molecular Identification of Enterocytozoon bieneusi Isolates from Nigerian Children. J Parasitol Res. 2011; 2011. PubMed | Google Scholar


35. Leelayoova S, Subrungruang I, Suputtamongkol Y, Worapong J, Petmitr PC, Mungthin M. Identification of genotypes of Enterocytozoon bieneusi from stool samples from human immunodeficiency virus-infected patients in Thailand. J Clin Microbiol. 2006; 44(8): 3001-3004. PubMed | Google Scholar


36. Muller A, Bialek R, Kamper A, Fatkenheuer G, Salzberger B, Franzen C. Detection of Microsporidia in Travelers with Diarrhea. J Clin Microbiol. 2001; 39(4): 1630-1632. PubMed | Google Scholar


37. Notermans DW, Peek R, de Jong MD, Wentink-Bonnema EM, Boom R, van Gool T. Detection and Identification of Enterocytozoon bieneusi and Encephalitozoon Species in Stool and Urine Specimens by PCR and Differential Hybridization. J Clin Microbiol. 2005; 43(2): 610-614. PubMed | Google Scholar


38. Janssen S, Hermans S, Knap M, Moekotte A, Rossatanga EG, Adegnika AA et al. Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon. PLoS Negl Trop Dis. 2015; 9(5): e0003769. PubMed | Google Scholar


39. Adamu H, Petros B. Intestinal protozoan infections among HIV positive persons with and without Antiretroviral Treatment (ART) in selected ART centers in Adama, Afar and Dire-Dawa, Ethiopia. Ethiop J Health Dev. 2010; 23(2). doi: 10.4314/ejhd.v23i2.53230. PubMed | Google Scholar


40. Adamu H, Wegayehu T, Petros B. High prevalence of diarrhoegenic intestinal parasite infections among non-ART HIV patients in Fitche Hospital, Ethiopia. PloS One. 2013; 8(8): e72634. PubMed | Google Scholar


41. Bachur TPR, Vale JM, Coêlho ICB, Queiroz TRBS de, Chaves C de S. Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy. Braz J Infect Dis Off Publ Braz Soc Infect Dis. 2008; 12(2): 115-122. PubMed | Google Scholar


42. Abate E, Belayneh M, Gelaw A, Idh J, Getachew A, Alemu S et al. The impact of asymptomatic helminth co-infection in patients with newly diagnosed tuberculosis in north-west Ethiopia. PloS One. 2012; 7(8): e42901. PubMed | Google Scholar


43. Taye B, Desta K, Ejigu S, Dori GU. The magnitude and risk factors of intestinal parasitic infection in relation to Human Immunodeficiency Virus infection and immune status, at ALERT Hospital, Addis Ababa, Ethiopia. Parasitol Int. 2014; 63(3): 550-556. PubMed | Google Scholar